Contributions to the optimal use of human blood. IX. Elimination of hepatitis B transmission by (potentially) infectious plasma derivatives.
D006526:Hepatitis C / Q000517:prevention & control*; D006525:Hepatitis, Viral, Human / Q000517:prevention & control*; D006801:Humans; D011420:Propiolactone / Q000494:pharmacology; D065227:Transfusion Reaction; D014466:Ultraviolet Rays
D011420:Propiolactone